Vitamin E added to levothyroxine for people with underactive thyroid
Tests vitamin E alongside levothyroxine in adults with hypothyroidism.
Key facts
- Who runs it
- Bangladesh Medical University
- Where
- Bangladesh1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Vitamin E Add-On Therapy, Thyroid Function & Oxidative Stress in Levothyroxine-Treated Hypothyroidism
- Status
- Enrolling by invitation
- People taking part
- 74 people, planned
- Starts
- Feb 2027
- Expected to end
- Jul 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- vitamin E
- placebo
- Record updated
- 25 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with hypothyroidism (an underactive thyroid) who take levothyroxine. It tests whether adding vitamin E changes thyroid function and oxidative stress, compared with a placebo (dummy capsule).
- Age
- Above 18 years up to 75 years
- Sex
- Men and women can join.
- Disease stage
- Hypothyroidism treated with levothyroxine.
- Earlier treatment
- People must have been taking Levothyroxine for at least 12 weeks.
Main reasons for not taking part
- Pregnant or breastfeeding women cannot join.
- People with active cancer cannot join.
- People with known allergy to vitamin E cannot join.
- People taking any other antioxidant drug, or any blood-thinning or antiplatelet drug, cannot join.
- People with acute illness, liver disease, a psychiatric disorder or high blood fats (hyperlipidemia) cannot join.
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age above 18 years up to 75 years
- Patient receiving Levothyroxine for at least 12 weeks
- Both male and female patient
Who cannot take part
- Patient taking any other antioxidant drug
- Patients taking any antiplatelet or anticoagulant drug
- Suffering from active malignancy
- Known hypersensitivity to vitamin E
- Patient with acute illness, liver disease, psychiatric disorder, hyperlipidemia
- Pregnancy or lactating mother
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to learn if vitamin E supplementation as an adjunct to levothyroxine therapy help to reduce oxidative stress, improve antioxidant defence mechanisms, and favourably influence thyroid hormone status, making it a promising therapeutic strategy for patients with hypothyroidism. The findings from this investigation aim to establish an evidence-based framework for integrating targeted antioxidant therapies into standard hypothyroid management strategies.
The 2 groups in the trial
- Vitamin E 400mg, participants received cap vitamin E 400mg orally once daily for 12 weeksTreatment being tested
Vitamin E capsule Alpha tocopherol, capsule, 400mg, 12weeks
Treatment: vitamin E
- participants received vitamin E placebo capsule matching vitamin E capsule orally once dailyPlacebo, for comparison
Vitamin E placebo capsule Capsule, 400mg, 12 weeks
Treatment: placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Vitamin E as add-on Therapy on Thyroid Function and Oxidative Stress in Levothyroxine Treated Hypothyroid Patients: A Randomized, Double-blind, Placebo-controlled Trial
- Plain-language title
- Vitamin E added to levothyroxine for people with underactive thyroidGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07781514, who can take part
- Record updated
- 25 August 2026